Effects of feminine hygiene products on the vaginal mucosal biome.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 3758931)

Published in Microb Ecol Health Dis on February 25, 2013

Authors

Bisiayo Fashemi1, Mary L Delaney, Andrew B Onderdonk, Raina N Fichorova

Author Affiliations

1: Union College Class of 2016, Boston Latin Academy Class of 2012, Brigham and Women's Hospital Student Success Jobs Program Intern at the Laboratory of Genital Tract Biology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA ; Laboratory of Genital Tract Biology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Boston, MA, USA.

Articles cited by this

The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis (1999) 3.95

The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis (2007) 3.93

Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biol Reprod (1997) 2.74

The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. J Infect Dis (2001) 2.49

Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod (1999) 2.00

In vitro and in vivo: the story of nonoxynol 9. J Acquir Immune Defic Syndr (2005) 1.99

Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus promotes the stability of the normal vaginal microflora and that L. gasseri and/or L. iners are more conducive to the occurrence of abnormal vaginal microflora. BMC Microbiol (2009) 1.97

Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis (2011) 1.94

Response to Neisseria gonorrhoeae by cervicovaginal epithelial cells occurs in the absence of toll-like receptor 4-mediated signaling. J Immunol (2002) 1.88

Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives. Biol Reprod (2004) 1.87

Correlation of behaviors with microbiological changes in vaginal flora. J Infect Dis (1999) 1.84

Distinct proinflammatory host responses to Neisseria gonorrhoeae infection in immortalized human cervical and vaginal epithelial cells. Infect Immun (2001) 1.62

Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect Immun (2006) 1.61

Vaginitis. Am Fam Physician (2011) 1.57

Post-coital vaginal douching is risky for non-regression of low-grade squamous intraepithelial lesion of the cervix. Gynecol Oncol (2010) 1.48

Qualitative assessment of vaginal microflora during use of tampons of various compositions. Appl Environ Microbiol (1987) 1.47

Maternal microbe-specific modulation of inflammatory response in extremely low-gestational-age newborns. MBio (2011) 1.42

Bacterial vaginosis. Transmission, role in genital tract infection and pregnancy outcome: an enigma. APMIS (2005) 1.32

Probiotics for the treatment of bacterial vaginosis. Cochrane Database Syst Rev (2009) 1.24

Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. MBio (2011) 1.21

The role of acidification in the inhibition of Neisseria gonorrhoeae by vaginal lactobacilli during anaerobic growth. Ann Clin Microbiol Antimicrob (2011) 1.04

Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo. Antimicrob Agents Chemother (2006) 1.02

In vitro inhibition of commercial douche products against vaginal microflora. Infect Dis Obstet Gynecol (2000) 0.95

Articles by these authors

Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe (2010) 4.54

Detection of bacteria in placental tissues obtained from extremely low gestational age neonates. Am J Obstet Gynecol (2008) 2.28

The vaginal microbiota and susceptibility to HIV. AIDS (2014) 2.24

CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung. Nat Med (2002) 2.22

Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci U S A (2010) 2.10

Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol (2008) 1.78

Colonization of second-trimester placenta parenchyma. Am J Obstet Gynecol (2008) 1.76

Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function. Glycoconj J (2008) 1.69

A disproportionate increase in IL-1beta over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth. Am J Obstet Gynecol (2004) 1.60

Microbiologic and histologic characteristics of the extremely preterm infant's placenta predict white matter damage and later cerebral palsy. the ELGAN study. Pediatr Res (2010) 1.57

Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study. Contraception (2006) 1.52

Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women. J Clin Microbiol (2005) 1.52

Cd1d-dependent regulation of bacterial colonization in the intestine of mice. J Clin Invest (2009) 1.49

Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus. J Infect Dis (2013) 1.43

Maternal microbe-specific modulation of inflammatory response in extremely low-gestational-age newborns. MBio (2011) 1.42

Tracheal tube obstruction in mechanically ventilated patients assessed by high-resolution computed tomography. Anesthesiology (2014) 1.41

Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome. Proc Natl Acad Sci U S A (2014) 1.40

Relationship Between Neonatal Blood Protein Concentrations and Placenta Histologic Characteristics in Extremely Low GA Newborns. Pediatr Res (2011) 1.34

Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection. Clin Infect Dis (2008) 1.24

Cervical inflammation and immunity associated with hormonal contraception, pregnancy, and HIV-1 seroconversion. J Acquir Immune Defic Syndr (2014) 1.23

RNA signatures allow rapid identification of pathogens and antibiotic susceptibilities. Proc Natl Acad Sci U S A (2012) 1.23

Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens. Proc Natl Acad Sci U S A (2013) 1.23

Novel vaginal microflora colonization model providing new insight into microbicide mechanism of action. MBio (2011) 1.21

Early postnatal blood concentrations of inflammation-related proteins and microcephaly two years later in infants born before the 28th post-menstrual week. Early Hum Dev (2011) 1.18

Systemic inflammation associated with mechanical ventilation among extremely preterm infants. Cytokine (2012) 1.17

Preclinical assessment of the proinflammatory potential of microbicide candidates. J Acquir Immune Defic Syndr (2004) 1.11

Quantitative microbiologic models for preterm delivery. J Clin Microbiol (2003) 1.10

Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women. Eur J Obstet Gynecol Reprod Biol (2004) 1.09

Enhanced susceptibility to infections in a diabetic wound healing model. BMC Surg (2008) 1.09

Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women. PLoS One (2012) 1.08

Inflammation-initiating illnesses, inflammation-related proteins, and cognitive impairment in extremely preterm infants. Brain Behav Immun (2013) 1.07

Mode of delivery and cord blood cytokines: a birth cohort study. Clin Mol Allergy (2006) 1.07

Systemic responses of preterm newborns with presumed or documented bacteraemia. Acta Paediatr (2011) 1.06

Injury enhances resistance to Escherichia coli infection by boosting innate immune system function. J Immunol (2008) 1.06

Mumps and ovarian cancer: modern interpretation of an historic association. Cancer Causes Control (2010) 1.03

Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo. Antimicrob Agents Chemother (2006) 1.02

Relationships among the concentrations of 25 inflammation-associated proteins during the first postnatal weeks in the blood of infants born before the 28th week of gestation. Cytokine (2011) 1.02

Association of epidural-related fever and noninfectious inflammation in term labor. Obstet Gynecol (2011) 1.02

Inferring dynamic signatures of microbes in complex host ecosystems. PLoS Comput Biol (2012) 1.01

Biomarkers of leukocyte traffic and activation in the vaginal mucosa. Biomarkers (2007) 1.01

Two-hit model of brain damage in the very preterm newborn: small for gestational age and postnatal systemic inflammation. Pediatr Res (2012) 0.99

Diversity of the gut microbiota and eczema in early life. Clin Mol Allergy (2008) 0.97

Gordonia bronchialis bacteremia and pleural infection: case report and review of the literature. J Clin Microbiol (2011) 0.97

The short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell induction. Immunity (2012) 0.97

The villain team-up or how Trichomonas vaginalis and bacterial vaginosis alter innate immunity in concert. Sex Transm Infect (2013) 0.96

Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells. Int J Cancer (2003) 0.95

Persistence after birth of systemic inflammation associated with umbilical cord inflammation. J Reprod Immunol (2011) 0.95

Expression and function of bactericidal/permeability-increasing protein in human genital tract epithelial cells. J Infect Dis (2006) 0.95

Is maternal obesity associated with sustained inflammation in extremely low gestational age newborns? Early Hum Dev (2013) 0.94

Trichomonasvirus: a new genus of protozoan viruses in the family Totiviridae. Arch Virol (2010) 0.94

Clinical isolates of Trichomonas vaginalis concurrently infected by strains of up to four Trichomonasvirus species (Family Totiviridae). J Virol (2011) 0.93

Acute histologic chorioamnionitis at term: nearly always noninfectious. PLoS One (2012) 0.93

Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women. BMC Infect Dis (2010) 0.93

Adherence to, invasion by, and cytokine production in response to serotype VIII group B Streptococci. Infect Immun (2004) 0.92

Inflammation biomarkers in vaginal fluid and preterm delivery. Hum Reprod (2013) 0.92

Detection of implantation-related cytokines in cervicovaginal secretions and peripheral blood of fertile women during ovulatory menstrual cycles. Fertil Steril (2004) 0.92

Toward early safety alert endpoints: exploring biomarkers suggestive of microbicide failure. AIDS Res Hum Retroviruses (2013) 0.92

Six-day randomized safety trial of intravaginal lime juice. J Acquir Immune Defic Syndr (2008) 0.91

Blood protein concentrations in the first two postnatal weeks associated with early postnatal blood gas derangements among infants born before the 28th week of gestation. The ELGAN Study. Cytokine (2011) 0.90

Urinary excretion of C5b-9 in severe preeclampsia: tipping the balance of complement activation in pregnancy. Hypertension (2013) 0.89

Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area. J Clin Microbiol (2004) 0.89

Systemic inflammation, intraventricular hemorrhage, and white matter injury. J Child Neurol (2012) 0.89

Homeostatic properties of Lactobacillus jensenii engineered as a live vaginal anti-HIV microbicide. BMC Microbiol (2013) 0.89

Polymorphism in intron 2 of the interleukin-1 receptor antagonist gene, local midtrimester cytokine response to vaginal flora, and subsequent preterm birth. Am J Obstet Gynecol (2004) 0.88

In vitro antimicrobial susceptibility of Propionibacterium acnes isolated from acne patients in northern Mexico. Int J Dermatol (2010) 0.87

Fetal-placental inflammation, but not adrenal activation, is associated with extreme preterm delivery. Am J Obstet Gynecol (2011) 0.87

Systemic inflammation associated with severe intestinal injury in extremely low gestational age newborns. Fetal Pediatr Pathol (2012) 0.85

Structure of a protozoan virus from the human genitourinary parasite Trichomonas vaginalis. MBio (2013) 0.84

Wound fluid bacterial levels exceed tissue bacterial counts in controlled porcine partial-thickness burn infections. Plast Reconstr Surg (2003) 0.84

Hyaluronic acid binding peptides prevent experimental staphylococcal wound infection. Antimicrob Agents Chemother (2006) 0.84

Cluster analysis of placental inflammatory proteins can distinguish preeclampsia from preterm labor and premature membrane rupture in singleton deliveries less than 28 weeks of gestation. Am J Reprod Immunol (2011) 0.83

Clinical evidence for the role of Trichomonas vaginalis in regulation of secretory leukocyte protease inhibitor in the female genital tract. J Infect Dis (2013) 0.83

Decontamination of Bacillus anthracis Spores: Evaluation of Various Disinfectants. Appl Biosaf (2009) 0.81

Commentary: Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136:701. J Infect Dis (2004) 0.81

Method for optimizing pulsed-field gel electrophoresis banding pattern data. J Mol Diagn (2003) 0.81

TNFA-308G>A polymorphism influences the TNF-alpha response to altered vaginal flora. Eur J Obstet Gynecol Reprod Biol (2006) 0.80

Sensitivity of Francisella tularensis to ultrapure water and deoxycholate: implications for bacterial intracellular growth assay in macrophages. J Microbiol Methods (2011) 0.80

Puerperal mastitis: a reproductive event of importance affecting anti-mucin antibody levels and ovarian cancer risk. Cancer Causes Control (2013) 0.80

Diversity of toxic shock syndrome toxin 1-positive Staphylococcus aureus isolates. Appl Environ Microbiol (2004) 0.79

No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis. Am J Obstet Gynecol (2005) 0.79

Vaginal nitric oxide in pregnant women with bacterial vaginosis. Am J Reprod Immunol (2006) 0.78

Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia. Am J Reprod Immunol (2014) 0.77

Association between vaginal 70-kd heat shock protein, interleukin-1 receptor antagonist, and microbial flora in mid trimester pregnant women. Am J Obstet Gynecol (2005) 0.77

Bacillus cereus septicemia attributed to a matched unrelated bone marrow transplant. Transfusion (2012) 0.77

The Development of Extremely Preterm Infants Born to Women Who Had Genitourinary Infections During Pregnancy. Am J Epidemiol (2015) 0.76

Can Monsel's Transmit Nosocomial Infections? A Microbiological Investigation. J Low Genit Tract Dis (2002) 0.76